Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Oliver Langford

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
Statistical Methods in Medical Research|March 20, 2016
Methods for meta-analysis of pharmacodynamic dose-response data with application to multi-arm studies of alogliptinOliver Langford, Jeffrey K Aronson, Gert van Valkenhoef, et al.
The British Journal of Psychiatry : the Journal of Mental Science|June 20, 2015
A randomised controlled trial of time-limited individual placement and support: IPS-LITE trialTom Burns, Ksenija Yeeles, Oliver Langford, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|January 29, 2026
Alzheimer's clinical research data via R packages: The alzverseMichael C Donohue, Kedir Hussen, Oliver Langford, et al.
Medrxiv : the Preprint Server for Health Sciences|December 25, 2025
Divergent latent classes of cognitive decline in the A4 and LEARN studiesRunpeng Li, Oliver Langford, Philip S Insel, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 22, 2026
Divergent patterns of cognitive decline in preclinical Alzheimer's disease: Implications for secondary prevention trialsRunpeng Li, Oliver Langford, Philip S Insel, et al.
Alzheimer'S Research & Therapy|October 15, 2025
Recruitment and retention in a preclinical AD trial: comparisons between academic and non-academic sitesMarina Ritchie, Kedir Hussen, Oliver Langford, et al.
Pharmaceutical Statistics|January 10, 2023
Natural cubic splines for the analysis of Alzheimer's clinical trialsMichael C Donohue, Oliver Langford, Philip S Insel, et al.
JAMA Network Open|July 6, 2021
Disparities by Race and Ethnicity Among Adults Recruited for a Preclinical Alzheimer Disease TrialRema Raman, Yakeel T Quiroz, Oliver Langford, et al.
Neurology|May 29, 2025
Changes in Daily Functioning in Association With Tau and Amyloid Among Unimpaired Older Adults With and Without Elevated AmyloidMark A Dubbelman, Andy Liu, Michael C Donohue, et al.
Communications Medicine|June 2, 2026
Exploring automated plasma phospho-tau217 assays for the diagnosis of Down syndrome-related Alzheimer's diseaseZinayida Schlachetzki, Oliver Langford, Matthew D Zammit, et al.
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Statistical Methods in Medical Research|March 20, 2016
Methods for meta-analysis of pharmacodynamic dose-response data with application to multi-arm studies of alogliptinOliver Langford, Jeffrey K Aronson, Gert van Valkenhoef, et al.
The British Journal of Psychiatry : the Journal of Mental Science|June 20, 2015
A randomised controlled trial of time-limited individual placement and support: IPS-LITE trialTom Burns, Ksenija Yeeles, Oliver Langford, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|January 29, 2026
Alzheimer's clinical research data via R packages: The alzverseMichael C Donohue, Kedir Hussen, Oliver Langford, et al.
Medrxiv : the Preprint Server for Health Sciences|December 25, 2025
Divergent latent classes of cognitive decline in the A4 and LEARN studiesRunpeng Li, Oliver Langford, Philip S Insel, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 22, 2026
Divergent patterns of cognitive decline in preclinical Alzheimer's disease: Implications for secondary prevention trialsRunpeng Li, Oliver Langford, Philip S Insel, et al.
Alzheimer'S Research & Therapy|October 15, 2025
Recruitment and retention in a preclinical AD trial: comparisons between academic and non-academic sitesMarina Ritchie, Kedir Hussen, Oliver Langford, et al.
Pharmaceutical Statistics|January 10, 2023
Natural cubic splines for the analysis of Alzheimer's clinical trialsMichael C Donohue, Oliver Langford, Philip S Insel, et al.
JAMA Network Open|July 6, 2021
Disparities by Race and Ethnicity Among Adults Recruited for a Preclinical Alzheimer Disease TrialRema Raman, Yakeel T Quiroz, Oliver Langford, et al.
Neurology|May 29, 2025
Changes in Daily Functioning in Association With Tau and Amyloid Among Unimpaired Older Adults With and Without Elevated AmyloidMark A Dubbelman, Andy Liu, Michael C Donohue, et al.
Communications Medicine|June 2, 2026
Exploring automated plasma phospho-tau217 assays for the diagnosis of Down syndrome-related Alzheimer's diseaseZinayida Schlachetzki, Oliver Langford, Matthew D Zammit, et al.
Pageof 3